Market Research Logo

Ajinomoto Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2015

Ajinomoto Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Ajinomoto Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2015’, provides an overview of the Ajinomoto Pharmaceuticals Co., Ltd.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Ajinomoto Pharmaceuticals Co., Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Ajinomoto Pharmaceuticals Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Ajinomoto Pharmaceuticals Co., Ltd.’s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Ajinomoto Pharmaceuticals Co., Ltd.’s pipeline products
Reasons to buy
  • Evaluate Ajinomoto Pharmaceuticals Co., Ltd.’s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Ajinomoto Pharmaceuticals Co., Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Ajinomoto Pharmaceuticals Co., Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Ajinomoto Pharmaceuticals Co., Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Ajinomoto Pharmaceuticals Co., Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Ajinomoto Pharmaceuticals Co., Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues


Ajinomoto Pharmaceuticals Co., Ltd. Snapshot
Ajinomoto Pharmaceuticals Co., Ltd. Overview
Key Information
Key Facts
Ajinomoto Pharmaceuticals Co., Ltd. - Research and Development Overview
Key Therapeutic Areas
Ajinomoto Pharmaceuticals Co., Ltd. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Ajinomoto Pharmaceuticals Co., Ltd. - Pipeline Products Glance
Ajinomoto Pharmaceuticals Co., Ltd. - Late Stage Pipeline Products
Phase III Products/Combination Treatment Modalities
Ajinomoto Pharmaceuticals Co., Ltd. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Ajinomoto Pharmaceuticals Co., Ltd. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Ajinomoto Pharmaceuticals Co., Ltd. - Drug Profiles
AJM-300
Product Description
Mechanism of Action
R&D Progress
budesonide
Product Description
Mechanism of Action
R&D Progress
elobixibat
Product Description
Mechanism of Action
R&D Progress
APY-0201
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Antagonize Notch-1 for Oncology and Hematological Disorders
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Inhibit IL-6 for Autoimmune Disorders and Allergies
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Inhibit NF-kappaB for Inflammation
Product Description
Mechanism of Action
R&D Progress
Ajinomoto Pharmaceuticals Co., Ltd. - Pipeline Analysis
Ajinomoto Pharmaceuticals Co., Ltd. - Pipeline Products by Target
Ajinomoto Pharmaceuticals Co., Ltd. - Pipeline Products by Route of Administration
Ajinomoto Pharmaceuticals Co., Ltd. - Pipeline Products by Molecule Type
Ajinomoto Pharmaceuticals Co., Ltd. - Pipeline Products by Mechanism of Action
Ajinomoto Pharmaceuticals Co., Ltd. - Recent Pipeline Updates
Ajinomoto Pharmaceuticals Co., Ltd. - Dormant Projects
Ajinomoto Pharmaceuticals Co., Ltd. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
mesalamine
Ajinomoto Pharmaceuticals Co., Ltd. - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Ajinomoto Pharmaceuticals Co., Ltd., Key Information
Ajinomoto Pharmaceuticals Co., Ltd., Key Facts
Ajinomoto Pharmaceuticals Co., Ltd. - Pipeline by Indication, 2015
Ajinomoto Pharmaceuticals Co., Ltd. - Pipeline by Stage of Development, 2015
Ajinomoto Pharmaceuticals Co., Ltd. - Monotherapy Products in Pipeline, 2015
Ajinomoto Pharmaceuticals Co., Ltd. - Partnered Products in Pipeline, 2015
Ajinomoto Pharmaceuticals Co., Ltd. - Partnered Products/ Combination Treatment Modalities, 2015
Ajinomoto Pharmaceuticals Co., Ltd. - Phase III, 2015
Ajinomoto Pharmaceuticals Co., Ltd. - Phase II, 2015
Ajinomoto Pharmaceuticals Co., Ltd. - Preclinical, 2015
Ajinomoto Pharmaceuticals Co., Ltd. - Pipeline by Target, 2015
Ajinomoto Pharmaceuticals Co., Ltd. - Pipeline by Route of Administration, 2015
Ajinomoto Pharmaceuticals Co., Ltd. - Pipeline by Molecule Type, 2015
Ajinomoto Pharmaceuticals Co., Ltd. - Pipeline Products by Mechanism of Action, 2015
Ajinomoto Pharmaceuticals Co., Ltd. - Recent Pipeline Updates, 2015
Ajinomoto Pharmaceuticals Co., Ltd. - Dormant Developmental Projects,2015
Ajinomoto Pharmaceuticals Co., Ltd. - Discontinued Pipeline Products, 2015
List of Figures
Ajinomoto Pharmaceuticals Co., Ltd. - Pipeline by Top 10 Indication, 2015
Ajinomoto Pharmaceuticals Co., Ltd. - Pipeline by Stage of Development, 2015
Ajinomoto Pharmaceuticals Co., Ltd. - Monotherapy Products in Pipeline, 2015
Ajinomoto Pharmaceuticals Co., Ltd. - Partnered Products in Pipeline, 2015
Ajinomoto Pharmaceuticals Co., Ltd. - Pipeline by Top 10 Target, 2015
Ajinomoto Pharmaceuticals Co., Ltd. - Pipeline by Top 10 Route of Administration, 2015
Ajinomoto Pharmaceuticals Co., Ltd. - Pipeline by Top 10 Molecule Type, 2015
Ajinomoto Pharmaceuticals Co., Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report